Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Tax Provisions: 2020-2025

Historic Tax Provisions for Tango Therapeutics (TNGX) over the last 4 years, with Sep 2025 value amounting to -$10,000.

  • Tango Therapeutics' Tax Provisions fell 118.52% to -$10,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $67,000, marking a year-over-year decrease of 65.28%. This contributed to the annual value of $208,000 for FY2024, which is 55.22% up from last year.
  • As of Q3 2025, Tango Therapeutics' Tax Provisions stood at -$10,000, which was down 128.57% from $35,000 recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Tax Provisions peaked at $185,000 during Q4 2021, and registered a low of -$21,000 during Q2 2021.
  • In the last 3 years, Tango Therapeutics' Tax Provisions had a median value of $34,500 in 2023 and averaged $38,300.
  • In the last 5 years, Tango Therapeutics' Tax Provisions skyrocketed by 3,233.33% in 2023 and then plummeted by 118.52% in 2025.
  • Tango Therapeutics' Tax Provisions (Quarterly) stood at $185,000 in 2021, then crashed by 47.57% to $97,000 in 2022, then crashed by 64.95% to $34,000 in 2023, then crashed by 76.47% to $8,000 in 2024, then slumped by 118.52% to -$10,000 in 2025.
  • Its last three reported values are -$10,000 in Q3 2025, $35,000 for Q2 2025, and $34,000 during Q1 2025.